Reviewed by PeptideGuide Research Team|Last updated February 15, 2026
Medical Disclaimer
This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide.Read full disclaimer
Back to Comparisons
Orforglipron vs Liraglutide
Complete side-by-side comparison of Orforglipron and Liraglutide.
Side-by-Side Comparison
Property
Orforglipron
Liraglutide
Name
Orforglipron
Liraglutide
Peptide Class
Non-peptide GLP-1 receptor agonist
GLP-1 receptor agonist
Category
Weight Loss and Metabolic
Weight Loss and Metabolic
Dosage Range
N/A
0.6 mg to 3 mg daily
Half-Life
N/A
13 hours
FDA Status
Investigational
Approved
Safety Rating
Research Only
Prescription Required
Cost Estimate
N/A
$800-1200/month
Orforglipron
Orforglipron is an investigational non-peptide GLP-1 receptor agonist primarily developed for weight loss and type 2 diabetes management. It works by ...
View full profile →Liraglutide
Liraglutide is a GLP-1 receptor agonist primarily used for weight management and Type 2 diabetes control. It mimics the action of the GLP-1 hormone, e...
View full profile →